Biogen (NasdaqGS: BIIB) and Eisai launched LEQEMBI IQLIK, a once-weekly subcutaneous injection for early Alzheimer's disease, ...

(Nasdaq: BIIB) announced today that the National Medical Products Administration (NMPA) of China has approved the subcutaneous formulation (subcutaneous autoinjector: SC-AI), the anti-amyloid beta (Aß ...

At-home subcutaneous lecanemab may ease the burden of frequent infusions, but clinicians still face key questions about ...

Alteogen has exported technology to global pharmaceutical company Novartis to convert intravenous injections into simpler ...

This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...

Huonslab, the R&D subsidiary of Huons Global, secured patents and PCT filings for 11 SC antibody formulations using HyDIFFUZE™.

Drug makers Biogen Inc. ( BIIB) and Japan's Eisai Co., Ltd. (ESALY.PK,4523.T,EII.SG) announced Thursday that the National Medical Products Administration or NMPA of China has approved LEQEMBI ...

Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection. The agent (Tecentriq Hybreza, ...

A person receives subcutaneous immunotherapy as an injection under the skin. This treatment method has shown similar effectiveness to intravenous (IV) infusions that healthcare professionals often use ...

Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia. Seventy-three patients were given CdA as a subcutaneous injection once daily for 7 days. Complete remission (CR) ...